PRRSv is infamously known for its impact on the worlds’ porcine industry. Since no efficient treatment is commercially available, this study evaluates the antiviral potential of four drugs derives from compounds which we have shown to inhibit PRRSv. Interestingly, two of these drugs, developed to treat HIV, have shown a significative decrease in viral replication in vitro.
Presenter : Marie-Jeanne Pesant, Faculté de médecine vétérinaire, Université de Montréal, marie-jeanne.pesant@umontreal.ca
Supervisor : Carl A Gagnon, 3200 rue Sicotte (bureau 3963), carl.a.gagnon@umontreal.ca
Authors, co-authors : Pesant, Marie-Jeanne1,3, Provost, Chantale2, Salmin, Abdulrahman Fuad, M. Jacques3, F. Beaudry1, C.A. Gagnon1,2,3
1Swine and Poultry Infectious Diseases Research Center [CRIPA-FRQ], Faculté de médecine vétérinaire, Université de Montréal, Québec, Canada, 2Molecular diagnostic laboratory, Centre de diagnostic vétérinaire de l’Université de Montréal, Québec, Canada, 3Research Group on Infectious Diseases in Animal Production [GREMIP], Faculté de médecine vétérinaire, Université de Montréal, Québec, Canada
Some text in the modal.
This website uses cookies to ensure that you get the best experience on our website, you can always change your preferences later or see
Here you can change the cookies you want to activate or not. Some changes need a page refresh to take effect please click the save button to ensure that all of your changes are applied correctly.